The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial).
Bone Marrow Transplant
; 51(10): 1404-1407, 2016 10.
Article
in En
| MEDLINE
| ID: mdl-27214073
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
Hematopoietic Stem Cell Transplantation
/
Transplantation Conditioning
/
Antibodies, Monoclonal
Type of study:
Etiology_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Bone Marrow Transplant
Journal subject:
TRANSPLANTE
Year:
2016
Document type:
Article
Affiliation country:
Spain